Psychiatry and Neurology, Neurology · Phoenix, AZ
NPI
1104260819
Since 2013
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
3805 E Bell Rd Ste 2400
Phoenix, AZ, 85032
Phone (602) 482-2116
Groups this clinician bills Medicare through
Medicare paid, 2024
$137K
11,473 services
Medicare patients, 2024
314
Average age 75
Drug cost, 2024
$3.1M
3,142 prescriptions
Company payments, 2025
$4,443
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rebecca L Jones was code J0585 (injection, onabotulinumtoxina, 1 unit), 10,756 times for 16 patients. In total Rebecca L Jones billed 11,473 services in 33 codes, and Medicare paid $137K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 10,756 | 16 | $4.98 | $54K |
| 99214 Office E&M - Established | Office | 208 | 155 | $87.91 | $18K |
| 99204 Office E&M - New | Office | 147 | 147 | $111.58 | $16K |
| 99215 Office E&M - Established | Office | 65 | 52 | $119.90 | $7,793 |
| 95816 Neurologic | Office | 61 | 36 | $276.30 | $17K |
| 99483 Office/Outpatient Services | Office | 38 | 32 | $199.63 | $7,586 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 37 | 36 | $12.27 | $454 |
| 99203 Office E&M - New | Office | 28 | 28 | $67.50 | $1,890 |
| 99205 Office E&M - New | Office | 13 | 13 | $162.48 | $2,112 |
By year: 2022 $90K for 3,955 services; 2023 $123K for 11,855 services; 2024 $137K for 11,473 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rebecca L Jones prescribed most often to Medicare patients was Gabapentin, with 301 prescriptions and refills. In total Rebecca L Jones wrote 3,142 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 301 | 393 | 86 | $4,432 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 179 | 339 | 43 | $6,900 |
| Tizanidine Hcl Generic | 176 | 280 | 74 | $1,333 |
| Levetiracetam Generic | 146 | 304 | 33 | $5,803 |
| Quetiapine Fumarate Generic | 133 | 187 | 28 | $1,699 |
| Kesimpta Pen Ofatumumab | 130 | 130 | 13 | $1.2M |
| Dalfampridine Er Dalfampridine | 127 | 133 | 14 | $34K |
| Donepezil Hcl Generic | 120 | 322 | 51 | $1,085 |
| Baclofen Generic | 104 | 188 | 27 | $1,997 |
| Sertraline Hcl Generic | 84 | 162 | 24 | $658 |
| Lamotrigine Generic | 74 | 160 | 20 | $1,820 |
| Propranolol Hcl Generic | 65 | 107 | 26 | $853 |
| Primidone Generic | 63 | 98 | 15 | $1,641 |
| Modafinil Generic | 62 | 62 | Under 11 | $1,530 |
| Amitriptyline Hcl Generic | 59 | 103 | 19 | $571 |
Brand drugs: 472 claims; generic drugs: 2,659 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rebecca L Jones $4,443 ($4,443 in general payments such as food, travel and fees) from 28 companies. The largest payer was Abbvie Inc. with $766.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 43 | $766 |
| Biogen, Inc. BIIB | 31 | $485 |
| Novartis Pharmaceuticals Corporation NVS | 32 | $463 |
| UCB, Inc. UCB.BR | 22 | $332 |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $280 |
| Celgene Corporation BMY | 11 | $248 |
| Pfizer Inc. PFE | 10 | $232 |
| Genentech USA, Inc. ROG.SW | 7 | $206 |
| Cycle Pharmaceuticals Inc | 12 | $193 |
| Amneal Pharmaceuticals LLC AMRX | 5 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.